West Pharmaceutical Services | WST - Assets

Stock Price
306.16
Daily Change
-3.54 -1.14%
Monthly
23.94%
Yearly
42.70%
Q2 Forecast
299.61

West Pharmaceutical Services reported $4.11B in Assets for its fiscal quarter ending in March of 2026.





Assets Change Date
Align Technology USD 6.23B 141K Dec/2025
Avanos Medical USD 1.07B 6M Dec/2025
Baxter International USD 20.06B 1.01B Dec/2025
Becton, Dickinson and Co. USD 54.84B 484M Dec/2025
Cerus USD 215.18M 2.11M Sep/2025
Charles River Laboratories USD 7.14B 378.39M Dec/2025
Cooper Companies USD 12.42B 29.4M Dec/2025
Dentsply International USD 5.43B 224M Dec/2025
Haemonetics USD 2.49B 48.73M Dec/2025
ICU Medical USD 4.05B 52.39M Dec/2025
Insulet USD 3.19B 161.1M Dec/2025
Integra LifeSciences USD 3.6B 44.45M Dec/2025
IQVIA Holdings USD 29.94B 1.22B Dec/2025
J&J USD 200.89B 1.68B Mar/2026
Medtronic USD 91.48B 139M Dec/2025
Merit Medical Systems USD 2.69B 54.92M Dec/2025
Neogen USD 3.36B 953K Dec/2025
OraSure Technologies USD 403.17M 19.93M Dec/2025
Quidel USD 5.77B 94.2M Dec/2025
Repligen USD 2.95B 25.99M Dec/2025
Rockwell Medical USD 52.62M 1.34M Jun/2025
Solventum Corp USD 14.29B 321M Dec/2025
STAAR Surgical USD 451.68M 4.68M Dec/2025
Terumo JPY 2.26T 362.12B Dec/2025
Utah Medical Products USD 122.54M 567K Dec/2025
West Pharmaceutical Services USD 4.11B 160.2M Mar/2026